PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF A PYRIMIDINE AMINOPYRAZOLE COMPOUND

The present disclosure relates to methods of making N 2 -(3-(2-(2H-1, 2, 3-triazol-2- yl)propan-2-yl)-1-cyclopropyl-1H-pyrazol-5-yl)- N 4-ethyl-5-(trifluoromethyl)pyrimidine-2,4- diamine and intermediates thereof. La présente invention concerne des procédés de fabrication de N 2 -(3-(2-(2H-1, 2, 3-t...

Full description

Saved in:
Bibliographic Details
Main Authors DEIGNAN, Jeffrey, SUDHAKAR, Anantha, BRAK, Katrien, REMARCHUK, Travis, JOHNSON, Trevor
Format Patent
LanguageEnglish
French
Published 30.05.2024
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present disclosure relates to methods of making N 2 -(3-(2-(2H-1, 2, 3-triazol-2- yl)propan-2-yl)-1-cyclopropyl-1H-pyrazol-5-yl)- N 4-ethyl-5-(trifluoromethyl)pyrimidine-2,4- diamine and intermediates thereof. La présente invention concerne des procédés de fabrication de N 2 -(3-(2-(2H-1, 2, 3-triazol-2-yl)propan-2-yl)-1-cyclopropyl-1H-pyrazol-5-yl)-N 4-éthyl-5-(trifluorométhyl)pyrimidine-2,4-diamine et de ses intermédiaires.
Bibliography:Application Number: WO2023US80675